BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pediatric Endocrine Society
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240315T120000
DTEND;TZID=America/New_York:20240315T130000
DTSTAMP:20240305T140730Z
CREATED:20240222T170411Z
LAST-MODIFIED:20240305T140730Z
UID:23572-1710504000-1710507600@pedsendo.org
SUMMARY:State of the Art; TREND SIG: Update on management of prolactinomas
DESCRIPTION:Session Type SIG: State of the Art: TREND SIG \nSession Title Update on management of prolactinomas \n Brief Description \nThe Consensus statement on Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement was published in 2023 in Nature Reviews Endocrinology. We would like to review the new guidelines with a focus on the section on prolactinomas in children and adolescents. In conjunction\, we would like to present challenging cases and go over management dilemmas as a group with a surgeon and endocrinologist present \nLearning Objectives  \n\nUnderstand new guidelines for treatment of prolactinoma in children and how to manage challenging cases\nUnderstand efficacy\, adverse effects and options for withdrawal of dopamine agonist therapy\, as well as indications for surgery in pediatric patients\nUnderstand the importance of genetic testing in pediatric prolactinoma\n\nSpeaker Name \nCraig Alter\, MD\, \nDirector of the Neuroendocrine Center in the Division of Endocrinology and Diabetes at Children’s Hospital Philadelphia. \nDr. Prashant Chittiboina\, \nPrincipal investigator of the Neurosurgery Unit for Pituitary and Inheritable Diseases at the Surgical Neurology Branch of the NINDS \nRegister Here
URL:https://pedsendo.org/event/state-of-the-art-trend-sig-update-on-management-of-prolactinomas/
END:VEVENT
END:VCALENDAR